Loading…
Underlying
Underlying Price
$6.01
Type
Call
Strike
2.5
Expiration
Dec 31, 2026
DTE
48d
Moneyness
ITM
Intrinsic
$3.51
IBRX 2.5 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Dec 31, 2026 | 48d | — | — | 0 | 0 |
| Jan 15, 2027 | 63d | $5.90 | +2.61% | 1 | 5,648 |
| Jan 21, 2028 | 434d | $5.87 | -3.77% | 2 | 15,806 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.